Discovery of ICOS‐Targeted Small Molecules Using Affinity Selection Mass Spectrometry Screening
Fuente:
Wiley Open Access
Guardado en:
| Autores principales: | Longfei Zhang, Laura Calvo‐Barreiro, Victor de Sousa Batista, Katarzyna Świderek, Moustafa T. Gabr |
|---|---|
| Formato: | Artículo Open Access |
| Publicado: |
Wiley
2024
|
| Materias: | |
| Acceso en línea: | |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
Structure‐Based Virtual Screening Identifies TREM2‐Targeted Small Molecules that Enhance Microglial Phagocytosis
por: Sungwoo Cho, et al.
Publicado: (2026)
por: Sungwoo Cho, et al.
Publicado: (2026)
Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
por: Jingjing Zhang, et al.
Publicado: (2024)
por: Jingjing Zhang, et al.
Publicado: (2024)
Research Progress and Clinical Translation Challenges of Small‐Molecule Inhibitors Targeting PD‐L1
por: Liang Qian, et al.
Publicado: (2026)
por: Liang Qian, et al.
Publicado: (2026)
Ligand Screening and Discovery Using Cocktail Soaking and Automated Microcrystal Electron Diffraction
por: Jieye Lin, et al.
Publicado: (2025)
por: Jieye Lin, et al.
Publicado: (2025)
Small‐Molecule Fluorescent Probes for Butyrylcholinesterase
por: Zibo Lin, et al.
Publicado: (2025)
por: Zibo Lin, et al.
Publicado: (2025)
Small‐Molecule Inhibitors Targeting PD‐1/PD‐L1 in Colorectal Cancer: Mechanisms, Challenges, and Clinical Prospects
por: Jianwei Wang, et al.
Publicado: (2025)
por: Jianwei Wang, et al.
Publicado: (2025)
Small‐Molecule KRAS Inhibitors by Tyrosine Covalent Bond Formation
por: Alexander D. Landgraf, et al.
Publicado: (2025)
por: Alexander D. Landgraf, et al.
Publicado: (2025)
Balinatunfib: A Clinical Oral Small Molecule TNFα Inhibitor
por: Alexander Dömling, et al.
Publicado: (2025)
por: Alexander Dömling, et al.
Publicado: (2025)
Current Small Molecule–Based Medicinal Chemistry Approaches for Neurodegeneration Therapeutics
por: Nitesh Sanghai, et al.
Publicado: (2024)
por: Nitesh Sanghai, et al.
Publicado: (2024)
Inflammaging and Immunosenescence in the Post‐COVID Era: Small Molecules, Big Challenges
por: Fabio Francavilla, et al.
Publicado: (2024)
por: Fabio Francavilla, et al.
Publicado: (2024)
Signaling Pathways and Promising Small‐Molecule Therapeutic Agents for Ischemic Stroke
por: Debasis Das, et al.
Publicado: (2025)
por: Debasis Das, et al.
Publicado: (2025)
Discovery of Potent Isoindolinone Inhibitors that Target an Active Conformation of PARP1 Using DNA‐Encoded Libraries
por: Kelly A. McCarthy, et al.
Publicado: (2024)
por: Kelly A. McCarthy, et al.
Publicado: (2024)
Discovery of Galactopyranose‐1‐carboxamides as a New Class of Small, Novel, Potent, Selective, and Orally Active Galectin‐3 Inhibitors
por: Cornelia Zumbrunn, et al.
Publicado: (2025)
por: Cornelia Zumbrunn, et al.
Publicado: (2025)
Exploring Small‐Molecule Modulators of Precursor miRNA Processing Associated With Glycolysis
por: Miho Fujiki, et al.
Publicado: (2026)
por: Miho Fujiki, et al.
Publicado: (2026)
Recent Advances of Quinoline‐Based Small Molecules as Kinase Inhibitors (2020–2024)
por: Sara Sultan, et al.
Publicado: (2025)
por: Sara Sultan, et al.
Publicado: (2025)
Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4
por: Raghuvir H. Gaonkar, et al.
Publicado: (2025)
por: Raghuvir H. Gaonkar, et al.
Publicado: (2025)
How to Find a Fragment: Methods for Screening and Validation in Fragment‐Based Drug Discovery
por: Tim Kirkman, et al.
Publicado: (2024)
por: Tim Kirkman, et al.
Publicado: (2024)
Small Molecule Antagonists of the DNA Repair ERCC1/XPA Protein‐Protein Interaction
por: Robert Obermann, et al.
Publicado: (2024)
por: Robert Obermann, et al.
Publicado: (2024)
Structure‐Based Discovery of Obeticholic Acid Derivatives as Novel Farnesoid X Receptor Partial Agonists with Improved Selectivity and Reduced Off‐Target Effects
por: Daniela Passeri, et al.
Publicado: (2026)
por: Daniela Passeri, et al.
Publicado: (2026)
Small Molecule Kinase Inhibitors with In Vitro β‐Hematin Formation and Plasmodium falciparum Protein Kinase G Inhibitory Activity Identified Using Machine Learning
por: Jessica L. Thibaud, et al.
Publicado: (2026)
por: Jessica L. Thibaud, et al.
Publicado: (2026)
Small‐Molecule Allosteric Inhibitors of Human Aspartate Transcarbamoylase Suppress Proliferation of Bone Osteosarcoma Epithelial Cells
por: Chao Wang, et al.
Publicado: (2024)
por: Chao Wang, et al.
Publicado: (2024)
Discovery of Novel Aminopyrimidines as Selective EP2 Receptor Antagonists
por: Isabelle Lyothier, et al.
Publicado: (2025)
por: Isabelle Lyothier, et al.
Publicado: (2025)
Discovery of Truncated Cyclic Peptides Targeting an Induced‐Fit Pocket on PCSK9
por: Philipp Grosche, et al.
Publicado: (2024)
por: Philipp Grosche, et al.
Publicado: (2024)
Towards New Anti‐Inflammatory Agents: Design, Synthesis and Evaluation of Molecules Targeting XIAP‐BIR2
por: Marc Farag, et al.
Publicado: (2024)
por: Marc Farag, et al.
Publicado: (2024)
Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV‐CA Binding Fragments
por: Stuart Lang, et al.
Publicado: (2024)
por: Stuart Lang, et al.
Publicado: (2024)
In Silico‐Enabled Discovery and Development of Potent and Selective CDK11 Inhibitors
por: Frankie S. Mak, et al.
Publicado: (2026)
por: Frankie S. Mak, et al.
Publicado: (2026)
Discovery and in vitro Evaluation of Novel Serotonin 5‐HT2A Receptor Ligands Identified Through Virtual Screening
por: Agata Zięba, et al.
Publicado: (2024)
por: Agata Zięba, et al.
Publicado: (2024)
Sertraline as a Scaffold for Antitrypanosoma Cruzi Drug Development: Design of Novel Derivatives and Computational Target Screening
por: Ali S. Mijoba, et al.
Publicado: (2025)
por: Ali S. Mijoba, et al.
Publicado: (2025)
Small‐Molecule Sarco/Endoplasmic Reticulum Ca 2+ ‐ATPase Activators Reverse Methylglyoxal‐Induced Inhibition through Nonantioxidant Mechanisms
por: Carlos Cruz‐Cortés, et al.
Publicado: (2025)
por: Carlos Cruz‐Cortés, et al.
Publicado: (2025)
Cover Feature: Improving Affinity while Reducing Kidney Uptake of CXCR4‐Targeting Radioligands Derived from the Endogenous Antagonist EPI‐X4 (ChemMedChem 6/2025)
por: Raghuvir H. Gaonkar, et al.
Publicado: (2025)
por: Raghuvir H. Gaonkar, et al.
Publicado: (2025)
Inducing Targeted Protein Degradation: From Chemical Biology to Drug Discovery and Clinical Applications. Edited by Philipp Cromm
por: Kirsten McAulay
Publicado: (2024)
por: Kirsten McAulay
Publicado: (2024)
Design, Synthesis, and Biological Evaluation of Small‐Molecule PD‐1/PD‐L1 Inhibitors Bearing a Rigid Benz[d]oxazole Skeleton
por: Bo Wei, et al.
Publicado: (2026)
por: Bo Wei, et al.
Publicado: (2026)
Estimation of In Vivo Half‐Life From In Vitro Metabolic Clearance, Protein, and Cell Membrane Affinity Assays
por: Carla Pou Miralbell, et al.
Publicado: (2025)
por: Carla Pou Miralbell, et al.
Publicado: (2025)
Elucidating the High Affinity Copper(II) Complexation by the Iron Chelator Deferasirox Provides Therapeutic and Toxicity Insight
por: Aixa M. Orta Rivera, et al.
Publicado: (2025)
por: Aixa M. Orta Rivera, et al.
Publicado: (2025)
Machine Learning‐Driven Discovery of GABA‐A Ligands with Pronounced Neuroprotective Efficacy and Resistance to P‐gp Efflux
por: Katarzyna Szafrańska, et al.
Publicado: (2025)
por: Katarzyna Szafrańska, et al.
Publicado: (2025)
Enhancing Binding Affinity to CGG/CGG Triad: Optimizing Naphthyridine Carbamate Dimer Derivatives with Varied Linker Lengths
por: Tomonori Shibata, et al.
Publicado: (2024)
por: Tomonori Shibata, et al.
Publicado: (2024)
An Internal Sulfur–Lone Pair Interaction Enabled the Discovery of Potent and Sub‐Family Selective PKMYT1 Inhibitors
por: Yazhou Wang, et al.
Publicado: (2026)
por: Yazhou Wang, et al.
Publicado: (2026)
Targeting N‐Methyl‐lysine Histone Demethylase KDM4 in Cancer: Natural Products Inhibitors as a Driving Force for Epigenetic Drug Discovery
por: Ilaria Cursaro, et al.
Publicado: (2024)
por: Ilaria Cursaro, et al.
Publicado: (2024)
Screening Methods for Cervical Cancer
por: Jingyan Li, et al.
Publicado: (2024)
por: Jingyan Li, et al.
Publicado: (2024)
Targeting Plasmodium falciparum Single‐Stranded DNA‐Binding Protein: Discovery of New Scaffold Compounds Effective against Drug‐Sensitive and Artemisinin‐Resistant Strains
por: Biswajit Naik, et al.
Publicado: (2025)
por: Biswajit Naik, et al.
Publicado: (2025)
Ejemplares similares
-
Structure‐Based Virtual Screening Identifies TREM2‐Targeted Small Molecules that Enhance Microglial Phagocytosis
por: Sungwoo Cho, et al.
Publicado: (2026) -
Small Molecule‐Drug Conjugates: Opportunities for the Development of Targeted Anticancer Drugs
por: Jingjing Zhang, et al.
Publicado: (2024) -
Research Progress and Clinical Translation Challenges of Small‐Molecule Inhibitors Targeting PD‐L1
por: Liang Qian, et al.
Publicado: (2026) -
Ligand Screening and Discovery Using Cocktail Soaking and Automated Microcrystal Electron Diffraction
por: Jieye Lin, et al.
Publicado: (2025) -
Small‐Molecule Fluorescent Probes for Butyrylcholinesterase
por: Zibo Lin, et al.
Publicado: (2025)